6635EGP
- Active ingredient
- phospholipid fraction from bovine lung
- Strength
- 54mg/1.2ml
- Form
- vial
- Manufacturer
- lyomark-pharma > pharmacon
- Route
- injection
Uses
Used for prevention and treatment of neonatal respiratory distress syndrome in premature infants.
Do not use if
No specific absolute contraindications are established when clinically indicated.
Side effects
May cause transient oxygen desaturation, bradycardia, airway obstruction, or reflux during administration.
Warnings
Administration requires specialized neonatal intensive care monitoring.
How it works
Natural pulmonary surfactant replacement that lowers alveolar surface tension and improves lung expansion.
Storage
Store refrigerated according to manufacturer recommendations.
